Joshua A. Feltman is the Chair of Wachtell, Lipton, Rosen & Katz’s Restructuring and Finance Department. He joined Wachtell Lipton as an associate in 2002 and became partner in 2010. He is a recognized leader in the burgeoning field of “liability management”, having advised on some of the largest and most novel transactions in the area, from Envision Healthcare to AMC Theatres.
With a cross-disciplinary practice, Feltman also focuses on acquisitions of leveraged entities in connection with in-court and out-of-court workouts.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2026 Lawdragon 500 Leading Global Bankruptcy & Restructuring Lawyers | 2026 | Restructuring, Finance, Liability Management |
| The 2025 Lawdragon 500 Leading Global Bankruptcy & Restructuring Lawyers | 2025 | Restructuring & Finance |
| The 2024 Lawdragon 500 Leading Global Bankruptcy & Restructuring Lawyers | 2024 | Restructuring & Finance |
| The 2023 Lawdragon 500 Leading Bankruptcy & Restructuring Lawyers | 2023 | Restructuring & Finance |
| 2022 Lawdragon 500 Leading U.S. Bankruptcy & Restructuring Lawyers | 2022 | Restructuring & Finance |
| The 2020 Lawdragon 500 Leading Global Restructuring & Insolvency Lawyers | 2020 | Restructuring & Finance |
| The 2020 Lawdragon 500 Leading U.S. Bankruptcy & Restructuring Lawyers | 2020 | Restructuring & Finance |
Feltman's recent engagements include advising:
- An ad hoc group of second lien noteholders in connection with the multi-billion dollar “dropdown” financial restructuring of AMC Theatres, including a first of its kind exchangeable notes issuance
- WHP Global in connection with the acquisition as a going concern of the business of retailer Express pursuant to Section 363 of the Bankruptcy Code
- Travelport Ltd. in connection with its 2023 financial restructuring, including a $570 million equity raise and over $2 billion in deleveraging
- Angelo Gordon and Centerbridge in connection with a $1.3 billion “dropdown” financing to and subsequent restructuring of Envision Healthcare and its Amsurg business
- Centerbridge and King Street Capital in connection with the liability management transactions of U.S. Renal
- King Street and others in connection with a “pari-+” first-lien notes financing of Team Health and follow-on first and second lien notes issuances to refinance additional Team Health debt
- Ares, Oaktree and others in connection with obtaining a controlling interest in TriMark through a financial restructuring and capital raise
- An ad hoc group of lenders and noteholders in connection with a new credit facility and uptier notes exchange offer of CURO Holdings, and with the eventual acquisition of a controlling interest in CURO following the company’s subsequent chapter 11 filing
- Expedia Inc. in connection with various financing transactions in the wake of the COVID-19 pandemic
Feltman received a B.A. in Social Studies magna cum laude from Harvard College in 1995, and an M.Phil. in Development Economics from Cambridge University in 1996. He completed a J.D. in 2002 magna cum laude at Harvard Law School, where he was an editor of the Harvard Law Review and a recipient of Harvard Law School’s Sears Prize.
Prior to law school, Feltman worked as a consultant and economist on regulatory and antitrust matters for Price Waterhouse and National Economic Research Associates. He enjoys taking his two dogs to the youth hockey games of his three sons.
Feltman is admitted to practice in the State of New York and the Southern and Eastern Districts of New York.
